Table 1 Clinico-pathological characteristics of patients with endometrial cancer
From: Endometrial cancer prognosis correlates with the expression of L1CAM and miR34a biomarkers
Clinicopathological characteristics | No recurrence | Recurrence |
|---|---|---|
N (%) | N (%) | |
Age at diagnosis | ||
 median (range) | 65 (40–84) | 68 (48–88) |
  ≤ 67 yrs | 34 (60.7) | 27 (47.4) |
  > 67 yrs | 22 (39.3) | 30 (52.6) |
BMI | ||
 median (range) | 28 (18–53) | 31 (21–80) |
Grade | ||
 G1 | 1 (1.8) | 6 (10.6) |
 G2 | 19 (33.9) | 17 (29.8) |
 G3 | 36 (64.3) | 34 (59.6) |
Histology | ||
 Adenocarcinoma (ADK) | 46 (82.1) | 46 (80.7) |
 Others | 10 (17.9) | 11 (19.3) |
Stage | ||
  ≤ IB | 21 (37.5) | 32 (56.1) |
  ≥ IB | 35 (62.5) | 25 (43.9) |
Adjuvant treatment | ||
 None | 11 (19.6) | 15 (26.3) |
 Radiotherapy | 30 (53.6) | 22 (38.6) |
 Chemotherapy | 8 (14.3) | 11 (19.3) |
 Radiation and chemotherapy | 7 (12.5) | 9 (15.8) |
Lymph nodes | ||
 Positive | 7 (12.5) | 6 (10.5) |
 Negative | 49 (87.5) | 51(89.5) |
Washing | ||
 Positive | 7 (12.5) | 6 (10.5) |
 Negative | 49 (87.5) | 51 (89.5) |
LVSI | ||
 Positive | 13 (23.2) | 13 (22.8) |
 Negative | 43 (76.8) | 38 (66.7) |
Hypertension | ||
 Yes | 27 (48.2) | 33 (57.9) |
 No | 29 (51.8) | 24 (42.1) |
Diabetes | ||
 Yes | 6 (10.7) | 9 (15.8) |
 No | 50 (89.3) | 48 (84.2) |